128 related articles for article (PubMed ID: 3920407)
1. Hormonal therapy of prostatic cancer.
Brendler CB
J Urol; 1985 Apr; 133(4):650-1. PubMed ID: 3920407
[No Abstract] [Full Text] [Related]
2. Hormonal therapy for prostate cancer.
Torti FM
N Engl J Med; 1984 Nov; 311(20):1313-4. PubMed ID: 6436701
[No Abstract] [Full Text] [Related]
3. Clinical effects of gonadotropin-releasing hormone analogue in metastatic carcinoma of prostate.
Smith JA; Glode LM; Wettlaufer JN; Stein BS; Glass AG; Max DT; Anbar D; Jagst CL; Murphy GP
Urology; 1985 Feb; 25(2):106-14. PubMed ID: 3918369
[TBL] [Abstract][Full Text] [Related]
4. Management of metastatic prostatic cancer.
Paulson DF
Urology; 1985 Feb; 25(2 Suppl):49-52. PubMed ID: 3918376
[TBL] [Abstract][Full Text] [Related]
5. Management of newly diagnosed metastatic carcinoma of the prostate.
Elder JS; Catalona WJ
Urol Clin North Am; 1984 May; 11(2):283-95. PubMed ID: 6428022
[TBL] [Abstract][Full Text] [Related]
6. Luteinizing hormone-releasing hormone (LH-RH) analogs in treatment of prostatic cancer. Clinical perspective.
Smith JA
Urology; 1986 Jan; 27(1 Suppl):9-15. PubMed ID: 3079936
[TBL] [Abstract][Full Text] [Related]
7. Testicular histology after prolonged treatment with a gonadotropin-releasing hormone analogue.
Smith JA; Urry RL
J Urol; 1985 Apr; 133(4):612-4. PubMed ID: 3920405
[TBL] [Abstract][Full Text] [Related]
8. Leuprolide: a gonadotropin-releasing hormone analog for the palliative treatment of prostatic cancer.
Wojciechowski NJ; Carter CA; Skoutakis VA; Bess DT; Falbe WJ; Mickle TR
Drug Intell Clin Pharm; 1986 Oct; 20(10):746-51. PubMed ID: 2429815
[TBL] [Abstract][Full Text] [Related]
9. LHRH analogues in the treatment of prostatic cancer. Introduction.
Dufour B
Br J Clin Pract Suppl; 1985 Mar; 37():2-3, 14-5. PubMed ID: 3931663
[No Abstract] [Full Text] [Related]
10. Leuprolide: a review of its effects in comparison with diethylstilboestrol in the treatment of advanced cancer of the prostate.
Garnick MB; Glode LM; Smith JA; Max DT
Br J Clin Pract; 1985 Feb; 39(2):73-6. PubMed ID: 3921047
[No Abstract] [Full Text] [Related]
11. Leuprolide versus diethylstilbestrol for previously untreated stage D2 prostate cancer. Results of a prospectively randomized trial.
Garnick MB
Urology; 1986 Jan; 27(1 Suppl):21-8. PubMed ID: 3079935
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of synthetic agonist analogue of gonadotropin-releasing hormone (leuprolide) on testicular androgen production in patients with carcinoma of prostate.
Santen RJ; Warner B
Urology; 1985 Feb; 25(2 Suppl):53-7. PubMed ID: 3918377
[TBL] [Abstract][Full Text] [Related]
13. Leuprolide versus diethylstilbestrol for metastatic prostate cancer.
Leuprolide Study Group
N Engl J Med; 1984 Nov; 311(20):1281-6. PubMed ID: 6436700
[TBL] [Abstract][Full Text] [Related]
14. Androgen suppression by a gonadotropin releasing hormone analogue in patients with metastatic carcinoma of the prostate.
Smith JA
J Urol; 1984 Jun; 131(6):1110-2. PubMed ID: 6427478
[TBL] [Abstract][Full Text] [Related]
15. A comparison of a powerful luteinizing hormone releasing hormone analogue agonist and estrogen in the treatment of advanced prostatic cancer.
Winfield H; Trachtenberg J
J Urol; 1984 Jun; 131(6):1107-9. PubMed ID: 6427477
[TBL] [Abstract][Full Text] [Related]
16. Combined androgen blockade: leuprolide and flutamide versus leuprolide and placebo.
Crawford ED; Goodman P; Blumenstein B
Semin Urol; 1990 Aug; 8(3):154-8. PubMed ID: 2119048
[No Abstract] [Full Text] [Related]
17. [New hormonal treatments of metastatic prostatic cancer. Review of the literature].
Dubost JJ; Sauvezie B; Ristori JM; Thevenet JP; Rampon S
Rev Rhum Mal Osteoartic; 1985 Oct; 52(10):577-85. PubMed ID: 3909364
[No Abstract] [Full Text] [Related]
18. Leuprolide: a review of its effects in comparison with diethylstilboestrol in the treatment of advanced cancer of the prostate.
Garnick MB; Glode LM; Smith JA; Max DT
Br J Clin Pract Suppl; 1985 Mar; 37():8-12, 20-4. PubMed ID: 3931665
[No Abstract] [Full Text] [Related]
19. Phase III studies in prostatic cancer with leuprolide acetate.
Seely JH
J Androl; 1987; 8(1):S23-6. PubMed ID: 3104263
[No Abstract] [Full Text] [Related]
20. Combined androgen blockade.
Crawford ED
Urology; 1989 Oct; 34(4 Suppl):22-6; discussion 46-56. PubMed ID: 2508291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]